Here’s whether Pfizer Inc. (PFE) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: RSI 62 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.15% over 10 days); 3-month momentum negative (-9.1%). Currently 14.6% off its 52-week high. Score: -4/7.
PFE is trading below its 200-day MA ($25.84) — a key warning sign the longer-term trend is under pressure. An RSI of 61.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -3.2% compares to +16.5% for SPY (trailed the market by 19.7%).
$10,000 invested 1 year ago→ $9,680 today
vs. S&P 500 (SPY) — same period trailed market by 19.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($25.84)
✗Above 50-day MA ($25.15)
✓RSI(14) neutral zone (30–70) — currently 61.9
✗Positive return (-3.2%)
!Within 10% of period high (−14.6%)
Period Range $24.54
$23.11$28.75
RSI (14) 61.9
0 · OversoldOverbought · 100
Key Metrics
Price$24.54
Period Return-3.2%
Period High$28.75
Period Low$23.11
Drawdown−14.6%
MA-50$25.15
MA-200$25.84
RSI (14)61.9
Avg Volume (30d)47.0M
vs. SPYtrailed by 19.7%
Return Rank#560 of 999
Trend Signals
Price is below the 200-day moving average ($25.84)